Alzheimer Disease
Conditions
Keywords
Alzheimer's Disease, Tau PET Scan, Health Disparities, Brain Aging
Brief summary
The purpose of this project is to study the aging brain among participants enrolled in the Health and Aging Brain Study: Health Disparities project . There are a number of things that can influence how people think as they age, including diabetes, depression, as well as our biology. In this study, the investigators seek to study the aging brain by using brain PET scans that create detailed pictures of the brain.
Detailed description
There are a number of things that can influence how we think as people age, including diabetes, depression, as well as our biology. In this study, the investigators are using PET scans with a tracer to create detailed pictures of the brain. This information will be used to help the investigators understand how the brain ages and in the future could be used to develop better diagnostics and treatments for Alzheimer's disease and memory loss in Mexican Americans, African Americans, and non-Hispanic whites. The goal of this study is to address this disparity by enrolling ethnically diverse participants in this study.
Interventions
DIAGNOSTIC_TESTPI-2620 tracer for Tau PET scan
Tau PET scans are obtained using PI-2620 tracer provided by Life Medical Imaging.
Sponsors
University of North Texas Health Science Center
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
50 Years to No maximum
Inclusion criteria
1. Enrolled in the Health and Aging Brain Study HD: Health Disparities project 2. Provided consent to re-contact 3. Willing and capable of undergoing PET scan of the head
Exclusion criteria
1. Inability to provide informed consent by self or by proxy. 2. Pregnant or breast feeding women\* 3. History of alcoholism or drug dependency/abuse within the last 2 years before screening 4. Hypersensitivity to the active substance or to any of the following excipients is contraindicated: sodium dihydrogen phosphate, phosphoric acid, sodium ascorbate, ethanol (anhydrous), water for injection 5. Participants may not be in this study if they do not meet the safety criteria to undergo imaging procedures.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Health Disparities in Aging | Through study completion in 2 years | Examine the prevalence of Tau burden among a multi ethnic cohort |
Countries
United States
Outcome results
None listed